Trinity Biotech plc (TRIB) — Cash Flow-to-Debt Ratio
Trinity Biotech plc (TRIB) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of $-71.45K could theoretically repay 0% of its total liabilities ($158.43 Million) in one year. See TRIB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Trinity Biotech plc Cash Flow-to-Debt Ratio (1993–2024)
Historical debt coverage capacity for Trinity Biotech plc across 32 annual periods. For the full cash flow conversion analysis, see Trinity Biotech plc (TRIB) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Trinity Biotech plc (1993–2024)
Year-by-year debt coverage analysis for Trinity Biotech plc. Check how high is Trinity Biotech plc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | $-4.19 Million | $138.47 Million | ▲ +78.2% |
| 2023 | -0.14x | $-11.56 Million | $83.38 Million | ▼ -1318.8% |
| 2022 | -0.01x | $-921.00K | $94.28 Million | ▼ -108.8% |
| 2021 | 0.11x | $13.24 Million | $119.21 Million | ▼ -38.0% |
| 2020 | 0.18x | $23.75 Million | $132.62 Million | ▲ +313.5% |
| 2019 | 0.04x | $5.47 Million | $126.36 Million | ▼ -33.0% |
| 2018 | 0.06x | $6.93 Million | $107.18 Million | ▼ -31.9% |
| 2017 | 0.10x | $12.11 Million | $127.42 Million | ▼ -2.8% |
| 2016 | 0.10x | $13.77 Million | $140.87 Million | ▲ +15.0% |
| 2015 | 0.09x | $12.34 Million | $145.07 Million | ▼ -75.2% |
| 2014 | 0.34x | $15.75 Million | $45.87 Million | ▲ +27.6% |
| 2013 | 0.27x | $11.71 Million | $43.48 Million | ▼ -62.4% |
| 2012 | 0.72x | $20.06 Million | $28.03 Million | ▼ -29.5% |
| 2011 | 1.02x | $20.48 Million | $20.17 Million | ▼ -13.8% |
| 2010 | 1.18x | $23.07 Million | $19.59 Million | ▲ +324.6% |
| 2009 | 0.28x | $14.73 Million | $53.10 Million | ▲ +64.5% |
| 2008 | 0.17x | $10.73 Million | $63.60 Million | ▼ -13.0% |
| 2007 | 0.19x | $15.35 Million | $79.13 Million | ▲ +115.5% |
| 2006 | 0.09x | $7.37 Million | $81.87 Million | ▼ -50.2% |
| 2005 | 0.18x | $9.21 Million | $50.98 Million | ▲ +14818.8% |
| 2004 | 0.00x | $42.00K | $34.69 Million | ▼ -98.7% |
| 2003 | 0.10x | $3.60 Million | $37.83 Million | ▼ -78.4% |
| 2002 | 0.44x | $11.65 Million | $26.36 Million | ▲ +79.0% |
| 2001 | 0.25x | $5.06 Million | $20.50 Million | ▼ -0.4% |
| 2000 | 0.25x | $3.02 Million | $12.19 Million | ▲ +44.8% |
| 1999 | 0.17x | $3.82 Million | $22.32 Million | ▲ +620.5% |
| 1998 | -0.03x | $-1.00 Million | $30.40 Million | ▲ +58.9% |
| 1997 | -0.08x | $-1.40 Million | $17.50 Million | ▲ +93.8% |
| 1996 | -1.29x | $-3.60 Million | $2.80 Million | ▼ -173.2% |
| 1995 | -0.47x | $-800.00K | $1.70 Million | ▲ +72.7% |
| 1994 | -1.72x | $-3.10 Million | $1.80 Million | ▼ -29.2% |
| 1993 | -1.33x | $-2.40 Million | $1.80 Million | — |